biolinerx hebrew ביוליין אר אקס bioline publicly traded drug development company headquartered israel shares traded nasdaq capital market tel aviv stock exchange firm established joint venture teva hadasit bioholdings jerusalem development authority yehuda zisapel executed initial public offering tel aviv stock exchange february raising million nis million tases largest biotech ipo july biolines adrs began trading nasdaq capital january firm announced deal genoscience french pharmaceutical company jointly develop market compound treatment hepatitis end novartis acquired stake company strategic move gain access israelisourced drug morris laster md alumnus downstate medical center ceo biolinerx replaced kinneret savitsky alumnus tel aviv university early savitsky replaced ceo bioline coo philip serlin october biolinerx drug development company promising compounds discovered firm leads preclinical trials engages companies develop commercializable company entered first major commercialization agreement partnered ikaria holdings inc develop bioline entered commercialization agreement cypress bioscience inc development compound agreement cypress canceled company taken ramius partial list drug compounds various stages development biolinerx unless indicated otherwise obtained regulatory approval relation diseases cited httpsenwikipediaorgwikibiolinerx